Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-05 Sale |
2024-02-06 6:32 pm |
OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer |
6,346 | $4.86 | $30,842 | 353,054 (Direct) |
View |
| 2024-01-31 Sale |
2024-02-02 7:02 pm |
OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer |
7,764 | $4.95 | $38,432 | 92,767 (Direct) |
View |
| 2023-07-07 Sale |
2023-07-11 8:00 pm |
OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer |
832 | $4.93 | $4,102 | 100,531 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 7:33 pm |
OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer |
6,416 | $4.24 | $27,204 | 101,363 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-25 Option Award |
2025-02-27 4:05 pm |
N/A 2035-02-24 |
Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Chief Medical Officer |
56,875 | $0 | 56,875 (Direct) |
View |
| 2024-08-02 Option Award |
2024-08-06 4:10 pm |
N/A 2034-08-01 |
Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Chief Medical Officer |
44,010 | $0 | 44,010 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-20 4:50 pm |
N/A 2034-06-16 |
Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Chief Medical Officer |
85,000 | $0 | 85,000 (Direct) |
View |
| 2024-02-03 Option Award |
2024-02-06 6:32 pm |
N/A 2034-02-02 |
OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer |
266,633 | $0 | 353,054 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 6:19 pm |
N/A 2033-06-08 |
Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-01-30 Option Award |
2023-02-01 7:34 pm |
N/A 2033-01-29 |
OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer |
272,223 | $0 | 324,446 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-15 8:01 pm |
N/A 2032-06-30 |
OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer |
56,667 | $0 | 122,223 (Direct) |
View |
Ownership |
2022-07-11 8:55 pm |
N/A N/A |
OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer |
0 | $0 | 302,223 (Direct) |
View |
| 2022-03-17 Option Award |
2022-03-18 5:12 pm |
N/A 2032-03-16 |
Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Director |
80,000 | $0 | 80,000 (Direct) |
View |
Ownership |
2022-03-18 5:11 pm |
N/A N/A |
Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2020-06-25 7:14 pm |
N/A 2029-10-17 |
Akouos Inc. | AKUS | Ozden Rabia Gurses Chief Development Officer |
0 | $0 | 188,059 (Direct) |
View |